|Hepatitis B Version 4.1|
| The following documents related to
hepatitis B have been elaborated for informative purpose only. They have
been written by Stuart Millinship.
This report has not been written by the Health
On the Net Foundation's team and the Foundation is not responsible for the
content of the Hepatitis B report.
Food and Drug Administration
Name of the Organism: Hepatitis E Virus
Hepatitis E Virus (HEV) has a particle diameter of 32-34 nm, a buoyant density of 1.29 g/ml in KTar/Gly gradient, and is very labile. Serologically related smaller (27-30 nm) particles are often found in feces of patients with Hepatitis E and are presumed to represent degraded viral particles. HEV has a single-stranded polyadenylated RNA genome of approximately 8 kb. Based on its physicochemical properties it is presumed to be a calici-like virus.
Name of Acute Disease:
The disease caused by HEV is called hepatitis E, or enterically transmitted non-A non-B hepatitis (ET-NANBH). Other names include fecal-oral non-A non-B hepatitis,and A-like non-A non-B hepatitis.
Note: This disease should not be confused with hepatitis C, also called parenterally transmitted non-A non-B hepatitis (PT-NANBH), or B-like non-A non-B hepatitis, which is a common cause of hepatitis in the U.S.
Nature of Disease:
Hepatitis caused by HEV is clinically indistinguishable from hepatitis A disease. Symptoms include malaise, anorexia, abdominal pain, arthralgia, and fever. The infective dose is not known.
Diagnosis of Human Illness:
Diagnosis of HEV is based on the epidemiological characteristics of the outbreak and by exclusion of hepatitis A and B viruses by serological tests. Confirmation requires identification of the 27-34 nm virus-like particles by immune electron microscopy in feces of acutely ill patients.
HEV is transmitted by the fecal-oral route. Waterborne and person-to-person spread have been documented. The potential exists for foodborne transmission.
Frequency of Disease:
Hepatitis E occurs in both epidemic and sporadic-endemic forms, usually associated with contaminated drinking water. Major waterborne epidemics have occurred in Asia and North and East Africa. To date no U.S. outbreaks have been reported.
Usual Course of Disease and Some Complications:
The incubation period for hepatitis E varies from 2 to 9 weeks. The disease usually is mild and resolves in 2 weeks, leaving no sequelae. The fatality rate is 0.1-1% except in pregnant women. This group is reported to have a fatality rate approaching 20%.
The disease is most often seen in young to middle aged adults (15-40 years old). Pregnant women appear to be exceptionally susceptible to severe disease, and excessive mortality has been reported in this group.
Analysis of Foods:
HEV has not been isolated from foods. No method is currently available for routine analysis of foods.
History of Recent Outbreaks:
Major waterborne epidemics have occurred in India (1955 and1975-1976), USSR (1955-1956), Nepal (1973), Burma (1976-1977), Algeria (1980-1981), Ivory Coast (1983-1984), in refugee camps in Eastern Suddan and Somalia (1985-6), and most recently in Borneo (1987). The first outbreaks reported in the American continents occurred in Mexico in late 1986. To date, no outbreak has occurred in the U.S., but imported cases were identified in Los Angeles in 1987. There is no evidence for immunity against this agent in the American population. Thus, unless other factors (such as poor sanitation or prevalence of other enteric pathogens) are important, the potential for spread to the U.S. is great. Good sanitation and personal hygiene are the best preventive measures.
|http://www.hon.ch/Library/Theme/HepB/hepe.html||Last modified: Fri Nov 1 2002|